Wednesday, March 29, 2023
Clinical Advances in
Read Overview
Supported by an independent educational grant from
Assistant Professor of Medicine
MD Anderson Cancer Center
Houston, Texas, United States
Associate Professor
Consultant Hematologist
Department for Internal Medicine
Secretary of the GLLSG
University Hospital of Cologne
Cologne, Germany
Professor of Medicine
Division of Hematology
Department of Internal Medicine
Mayo Clinic College of Medicine
Rochester, Minnesota, United States
University Professor of Clinical Hematology
Head, Hematology Department
University Hospital of Nantes
Nantes, France
Clinical Hematologist
Leukemia Research Group
Alfred Hospital
Melbourne, Australia
Professor of Medicine, Division of Hematology, The Ohio State University Comprehensive Cancer Center – Columbus, United States
Disclosure: Courtney D. DiNardo, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: AbbVie; Agios; Bristol Myers Squibb Company; Celgene; Foghorn; Gilead; Novartis; Takeda
Received grants for clinical research from: AbbVie; Agios; Astex; Bristol Myers Squibb Company; Calithera; Celgene; Cleave
Owns stock, stock options, or bonds from: Notable Labs
Has disclosed no relevant financial relationships.
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Janssen, Roche, Novartis, AbbVie, Gilead, Celgene, ArQule, AstraZeneca, Oxford Biomedica (UK), BeiGene
Served as a speaker or a member of a speakers bureau for: Janssen, Gilead, Roche, AbbVie, Novartis Celgene, Adaptive Biotechnologies, BeiGene, AstraZeneca
Received grants for clinical research from: Janssen, Gilead, Roche, AbbVie, BeiGene, AstraZeneca
Disclosure: Shaji K. Kumar, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: AbbVie; Amgen; Antengene; AstraZeneca; Beigene; Bristol Myers Squibb Company; Bluebird Bio; Genentech; Janssen; Kite; Oncopeptides; Roche
Received grants for clinical research from: AbbVie; Amgen; AstraZenca; Bristol Myers Squibb Company; Carsgen; Genentech; Janssen; Kite; Merck; Novartis; Roche; Takeda; Tenebio
Disclosure: Philippe M. Moreau, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: AbbVie; Amgen; Bristol Myers Squibb Company; Celgene; Janssen; Sanofi
Steering Committee Chair
Disclosure: Andrew Wei, MBBS, PhD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: AbbVie; Astellas; AstraZeneca; Bristol Myers Squibb Company; Celgene; Genentech; Janssen; Macrogenics; Novartis; Pfizer; Servier
Served as a speaker or a member of a speakers bureau for: AbbVie; Bristol Myers Squibb Company; Celgene; Novartis
Received grants for clinical research from: AbbVie; Amgen; AstraZeneca; Bristol Myers Squibb Company; Celgene; F. Hoffman-La Roche; Novartis; Servier
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: AbbVie, Janssen, Pharmacyclics, BeiGene, AstraZeneca, ArQule
Received grants for clinical research from: Janssen, Morphosys, Karyopharm, Pharmacyclics
